Table 2 Relationships between ANXA8 expression in epithelial ovarian cancer and clinicopathological parameters
Characteristics | n | Low | High | High positive rate (%) | P-value | ||
|---|---|---|---|---|---|---|---|
(−) | (+) | (++) | (+++) | ||||
FIGO stage | 0.006* | ||||||
 I–II | 35 | 6 | 9 | 8 | 12 | 57.14 | |
 III–IV | 46 | 2 | 5 | 21 | 18 | 84.78 | |
Differentiation | 0.401 | ||||||
 Well–moderate | 38 | 3 | 9 | 13 | 13 | 68.42 | |
 Poor | 43 | 5 | 5 | 16 | 17 | 76.74 | |
LN metastasis | 0.414 | ||||||
 No | 45 | 6 | 8 | 15 | 16 | 68.89 | |
 Yes | 19 | 0 | 4 | 8 | 7 | 78.95 | |
 No lymphadenectomy | 17 | 2 | 2 | 6 | 7 | 76.47 | |
Pathologic type | 0.673 | ||||||
 Serous | 40 | 3 | 8 | 15 | 14 | 72.50 | |
 Mucinous | 9 | 1 | 3 | 3 | 2 | 55.56 | |
 Endometrioid | 11 | 2 | 1 | 3 | 5 | 72.72 | |
 Clear cell carcinoma | 8 | 0 | 1 | 2 | 5 | 87.50 | |
 Poorly differentiated adenocarcinoma | 13 | 2 | 1 | 6 | 4 | 76.92 | |